Foxx Development Holdings Inc. (NASDAQ:FOXX) Short Interest Update

Foxx Development Holdings Inc. (NASDAQ:FOXX) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 86,407 shares, an increase of 27.5% from the December 15th total of 67,779 shares. Approximately 1.9% of the company’s shares are short sold. Based on an average daily volume of 70,908 shares, the days-to-cover ratio is currently 1.2 days. Based on an average daily volume of 70,908 shares, the days-to-cover ratio is currently 1.2 days. Approximately 1.9% of the company’s shares are short sold.

Institutional Trading of Foxx Development

A hedge fund recently raised its stake in Foxx Development stock. JPMorgan Chase & Co. increased its stake in Foxx Development Holdings Inc. (NASDAQ:FOXX) by 170.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,947 shares of the company’s stock after purchasing an additional 3,121 shares during the period. JPMorgan Chase & Co. owned approximately 0.07% of Foxx Development worth $27,000 as of its most recent filing with the SEC. 60.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Foxx Development in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Foxx Development Stock Performance

NASDAQ:FOXX traded up $0.01 during mid-day trading on Monday, hitting $4.09. The company had a trading volume of 16,998 shares, compared to its average volume of 31,477. The firm has a market cap of $27.73 million, a P/E ratio of -2.84 and a beta of -0.21. Foxx Development has a fifty-two week low of $1.71 and a fifty-two week high of $11.00. The business’s fifty day moving average is $4.18 and its two-hundred day moving average is $4.92.

Foxx Development (NASDAQ:FOXX) last released its quarterly earnings results on Tuesday, November 18th. The company reported ($0.42) earnings per share (EPS) for the quarter. The company had revenue of $20.22 million during the quarter.

Foxx Development Company Profile

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.